Volume 117, Issue 2 pp. 336-340
Article

Fully Implantable Hearing Aids in Patients With Congenital Auricular Atresia

Ralf Siegert MD, DDS, PhD

Corresponding Author

Ralf Siegert MD, DDS, PhD

Prosper-Hospital, Academic Teaching Hospital of the Ruhr-University Bochum, Recklinghausen, Germany

Dr. R. Siegert, Prosper-Hospital, Muehlenstrasse 27, D-45659 Recklinghausen, Germany.Search for more papers by this author
Stefan Mattheis MD

Stefan Mattheis MD

Prosper-Hospital, Academic Teaching Hospital of the Ruhr-University Bochum, Recklinghausen, Germany

Search for more papers by this author
James Kasic MS, MBA

James Kasic MS, MBA

Otologics, Boulder, Colorado, U.S.A.

Search for more papers by this author
First published: 02 January 2009
Citations: 65

This paper was presented in parts at MERO, Zürich, Switzerland, July 27–30, 2006.

This study was approved by the relevant local ethics committee of the University of Bochum (#2280, 25.05.2004). The implantable hearing devices were produced and supplied for this study without any charge by Otologics, LLC, Boulder, CO. There are no other commitments between the first two authors (Siegert and Mattheis) and the company. The third author (Kasic) is an employee of the Otologics who has contributed to the technical modifications described in this paper and has revised the text.

Abstract

Introduction: Patients with congenital auricular atresia suffer from a conductive hearing loss (HL) with an air-bone gap of 50 to 60 dB. Conventional bone conducting or bone anchored hearing aids are treatment options with several disadvantages and a biophysical limitation of almost no sound attenuation in the skull bone. Surgical construction of the sound conducting apparatus has been performed by others and modified by us into a three-step procedure with in vivo prefabrication of the external ear canal and the tympanic membrane. Although the results improved after inauguration of our modifications, there still remains an air-bone gap that makes air conducting hearing aids necessary in many patients. Implantable hearing aids have been developed for patients with perceptional HL and normal middle ear function but not for patients with middle ear disease or malformation.

Objectives: Our objectives were to improve the hearing results of auricular atresia.

Study Design: Prospective.

Methods: The surgical instruments, the transducer, and the operative technique of the only fully implantable hearing aid (Otologics Fully Implantable Middle Ear Transducer) clinically available were modified. They were implanted in five patients with congenital auricular atresia and their audiologic outcome evaluated.

Results: After activation and fitting of the devices, patients experienced an improvement of sound-field thresholds up to 50 dB HL. The mean functional gain in a three frequency pure-tone average was approximately 35 dB HL.

Conclusions: This technique appears to provide a completely new dimension for the audiologic rehabilitation of patients with severe malformation of the middle ear.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.